Advertisement
Direct-acting antiviral therapies are associated with high sustained virologic response rates in hepatitis C virus-associated mixed cryoglobulinemia syndrome

Direct-Acting Antiviral Therapies Beneficial in HCV-MCS

0
High sustained virologic response at 12 weeks in hep C virus-linked mixed cryoglobulinemia syndrome
New research suggests that doctors don't warn younger women when they're at risk for cardiovascular disease as often as they warn men. And once younger women suffer an ST-segment elevation myocardial infarction

Gender Gap Appears to Continue in Cardiovascular Care

0
Younger women less likely than men to be warned of risk, get same treatments or survive after MI
For patients with hepatocellular carcinoma after radiofrequency ablation

Sartans Improve Survival, Time to Recurrence in Liver Cancer

0
Sartans up outcomes in patients with hepatocellular carcinoma after radiofrequency ablation
For pregnant women with gestational diabetes mellitus or type 2 diabetes

Cellphone System Ups Glucose Self-Monitoring in Pregnancy

0
For pregnant women, improvement in compliance and satisfaction with use of CIT system

JAK Inhibitors May Help Treat Hair Loss

0
Early experimental study shows promise; more research needed
Viekira Pak and Technivie appear linked to serious liver damage in patients with advanced liver disease

FDA Requires New Warning on Two Hepatitis C Drugs

0
Cautionary label will be added to Viekira Pak and Technivie, agency says
Serogroup B meningococcal vaccination is recommended for adolescents and young adults aged 16 to 23 years to provide short-term protection from most strains of serogroup B meningococcal disease

MenB Vaccine Recommended for 16- to 23-Year-Olds

0
Preferred age for serogroup B meningococcal vaccination is 16 to 18 years
Most male adolescents in the United States aren't receiving the human papillomavirus vaccine alongside their other scheduled inoculations

CDC: Too Few Male Adolescents Receiving HPV Vaccine

0
Physicians failing to recommend it or adequately explain its benefits to parents
Nitrous oxide is a safe anesthetic for surgery patients who have or are at risk for cardiovascular disease

ASA: Nitrous Oxide Deemed Safe for Surgical Patients With CVD

0
Study eases concerns about the use of the anesthetic in non-cardiac procedures
An intensive lifestyle intervention can reduce gastrointestinal symptoms among overweight and obese adults with type 2 diabetes

Intensive Lifestyle Intervention Improves GI Symptoms in T2DM

0
Improvements in gastrointestinal symptoms greatest during first year, which also sees most weight loss